Canaccord Publishes Report on Specialty Pharmaceuticals

In its report, Canaccord writes, “We will see a generic Lipitor launch this week, with November 30 marking the biggest generic launch in history with broad implications across healthcare including the generics, PBMs, retail pharmacies, wholesalers and Pfizer, among others. The launch will also likely come with more media coverage given Pfizer's well advertised and pre-contracted plans to retain a much larger brand share than is typically seen.”

Companies included in the Canaccord report are: Pfizer (NYSE: PFE), Watson Pharmaceuticals (NYSE: WPI), Teva Pharmaceutical Industries (NASDAQ: TEVA), and Mylan (NASDAQ: MYL).